| 1MMAE |
|---|
Analyte not found
Applications
Trastuzumab mcMMAF on bioZen 1.8 µm SEC-3
24682
Separation Mode: Gel Filtration Chromatography (GFC)
Gel Filtration Chromatography (GFC)
SEC-3
HPLC
Pharmaceutical/Biopharmaceutical
Life Science
Therapeutic / Clinical
Therapeutic / Clinical
Analytes
Details
LC Conditions (App ID: 24682)
Column: | ||||||
Brand Name: | ||||||
Part No: | ||||||
Phase Name: SEC-3 | ||||||
Elution Type: Isocratic | ||||||
Mobile Phase: A: 50 mM K2PO4 100 mM Na2SO4, pH 6.8
| ||||||
Gradient Profile:
| ||||||
Flow Rate: 0.2 mL/min | ||||||
Temperature: 25°C | ||||||
Detection: UV-Vis Abs.-Variable Wave.(UV) @ 280 nm (25°C) |
Order Items Used in This Application
00H-4772-E0
bioZen 1.8 µm SEC-3, LC Column 300 x 4.6 mm, Ea
Qty:
Similar Applications
search
MMAE
bioZen 3.6 µm Intact XB-C8, LC Column 150 x 2.1 mm, Ea
Reversed Phase
bioZen 3.6 µm Intact XB-C8, LC Column 150 x 2.1 mm, Ea
Reversed Phase
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
